Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Healthcare Brands International (HBI) has completed the sale of Antula Healthcare to Meda, a specialty pharmaceutical company, for SEK1.8bn.
Subscribe to our email newsletter
Antula Healthcare, an independent over-the-counter (OTC) healthcare company in the Nordic markets, is the wholly owned Swedish subsidiary of HBI.
The sale to Meda will allow HBI to continue to outpace market growth in the Nordics and help Meda become a major international player in the OTC market.
HBI chairman Barry Clare said Antula’s management team has achieved sustainable revenue growth through innovative marketing, line extensions, and new product launches.
"We are particularly proud of their accomplishment in developing and building their own flagship product SB-12, a medicated mouthwash, into a SEK200m product in the Nordic market," Clare said.